Search...
Features
Assets
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Halozyme Therapeutics (HALO) Q1 2021 Earnings
HALO
23
Feb
Confirmed
Q2 2020
Q3 2020
Q4 2020
Q1 2021
-0.04
0.15
0.35
0.54
Details
Expected EPS
0.54
Actual EPS
0.5
Surprise EPS
-0.04
Surprise Percent
+7.41%
Description
Halozyme Therapeutics (HALO) has reported earnings of 0.5 per share for Q1 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login